Pfizer Anchors U.S. Gram-Positive Bacterial Infections Treatment Market Climb from USD 18.6 billion in 2026 and USD 33.9 billion by 2036 at 6.2% CAGR ROCKVILLE, MARYLAND , August 27, 2026 — The gram positive bacterial infections treatment market is valued at USD 18.6 billion in 2026 and is forecast to reach USD 33.9 billion by 2036. The market is projected to expand at a compound annual growth rate (CAGR) of 6.2% over the 2026–2036 period. The market reached USD...

IQVIA Leads U.S. Push as Decentralized Clinical Trials CRO Market Moves from USD 8.7 billion in 2026 to USD 23.4 billion by 2036 by 2036 at 10.4% CAGR ROCKVILLE, MARYLAND , August 27, 2026 – The decentralized clinical trials contract research organization (CRO) market reached USD 7.9 billion in 2025. Demand is projected to increase from USD 8.7 billion in 2026 to USD 23.4 billion by 2036, recording a 10.4% CAGR and creating a USD 14.7 billion absolute opportunity between...

The United States Parasite Cleanse Market is witnessing growing interest as consumers increasingly focus on digestive wellness, preventive healthcare, and natural health products. Demand is supported by the expanding dietary supplements sector, rising awareness of gut health, and the availability of herbal and botanical formulations through online and specialty retail channels. The Parasite Cleanse Market was valued at US$ 814.74 million in 2025 and is projected to reach US$ 1,123.98 million...

The United States FAM20B Gene (XYLK Antibody) Market is gaining attention with the expansion of biomedical research, molecular biology, and antibody-based research tools. FAM20B, also known as glycosaminoglycan xylosylkinase, is being investigated for its role in cellular processes, skeletal development, and extracellular matrix biology, supporting demand for specialized antibodies in research applications. The FAM20B Gene (XYLK Antibody) Market was valued at US$ 1.45 billion in 2025 and is...

The United States Pyrimethamine Market is supported by the continued clinical use of pyrimethamine as an antiparasitic therapy, particularly for toxoplasmosis and selected infectious disease applications. The drug remains an important component of recommended toxoplasmosis treatment, typically administered with sulfadiazine and folinic acid, especially for patients with severe disease or compromised immunity. The Pyrimethamine Market is projected to grow from US$ 1.31 billion in 2025 to US$...

The United States Natriuretic Peptide Market is expanding with the increasing use of B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) testing for the diagnosis, risk assessment, and monitoring of heart failure. These biomarkers are widely used to help rule out heart failure in patients presenting with symptoms such as shortness of breath and can also support disease severity and prognosis assessment. The Natriuretic Peptide Market is projected to grow from US$ 1.38 billion...

The United States 5-Hydroxytryptamine Receptor Market holds the largest share within North America, supported by a high burden of central nervous system disorders, strong pharmaceutical research capabilities, and increasing healthcare expenditure. Rising demand for serotonin receptor-targeted drugs, ongoing innovation in neuropsychiatric therapeutics, and expanding clinical trials are driving market growth across the country. The 5 -Hydroxytryptamine Receptor Market is projected to grow from...

The United States Skeletal Dysplasia Market accounts for the largest share in North America, supported by advanced genetic research capabilities, specialized treatment centers, and a strong focus on rare disease management. Increasing diagnosis rates through next-generation sequencing, expanding access to genetic counseling, and growing investments in orphan drug development are driving demand for effective therapies across the country. The Skeletal Dysplasia Market is projected to grow from...

The United States Hyaluronidase Market holds the largest share in North America, supported by high healthcare expenditure, widespread adoption of aesthetic treatments, and a well-established pharmaceutical industry. Increasing demand for dermal filler reversal procedures, enhanced subcutaneous drug delivery, and advanced ophthalmic surgeries continues to drive the use of hyaluronidase across the country. The Hyaluronidase Market was valued at US$ 24.85 Billion in 2025 and is projected to...

The United States Single-Use Bioprocessing Market accounts for the largest share in North America, supported by a well-established biopharmaceutical industry, extensive investments in biologics manufacturing, and widespread adoption of advanced bioprocessing technologies. Increasing demand for monoclonal antibodies, vaccines, and personalized medicines is driving the use of single-use bioreactors, filtration systems, and disposable process components across the country. The Single-Use...

The United States Hydroxychloroquine Market holds the largest share in North America, supported by a substantial patient population affected by autoimmune diseases, robust healthcare spending, and well-established pharmaceutical manufacturing capabilities. Rising demand for effective long-term treatment options, expanding access to specialty care, and continuous monitoring of drug safety and efficacy contribute to market growth. The Hydroxychloroquine Market is projected to grow from US$...

The United States Cannabis Cultivation Market represents the largest share within North America, supported by the legalization of cannabis across numerous states, increasing demand for medical and recreational cannabis products, and substantial investments in cultivation infrastructure. The adoption of precision agriculture technologies, automation, and indoor growing systems is enhancing crop quality, yield, and operational efficiency. The Cannabis Cultivation Market is projected to grow...